Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yusuke Iguchi

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
The Review of Scientific Instruments|September 4, 2009
Development of special rotor for centrifugal separation of isotopes in solid pure metalsMasao Ono, Masanori Sueyoshi, Satoru Okayasu, et al.
Physical Review Letters|May 27, 2023
Microscopic Imaging Homogeneous and Single Phase Superfluid Density in UTe_{2}Yusuke Iguchi, Huiyuan Man, S M Thomas, et al.
Bioorganic & Medicinal Chemistry|April 7, 2023
Discovery of FXR/PPARγ dual partial agonistYukiko Yamashita, Keigo Gohda, Yusuke Iguchi, et al.
Bioorganic & Medicinal Chemistry|July 4, 2020
N<sup>1</sup>-Substituted benzimidazole scaffold for farnesoid X receptor (FXR) agonists accompanying prominent selectivity against vitamin D receptor (VDR)Arisa Masuda, Keigo Gohda, Yusuke Iguchi, et al.
ACS Medicinal Chemistry Letters|February 20, 2018
Nonacidic Chemotype Possessing <i>N</i>-Acylated Piperidine Moiety as Potent Farnesoid X Receptor (FXR) AntagonistsNaoki Teno, Yukiko Yamashita, Yusuke Iguchi, et al.
Biological & Pharmaceutical Bulletin|October 2, 2022
Hyodeoxycholic Acid (HDCA) Prevents Development of Dextran Sulfate Sodium (DSS)-Induced Colitis in Mice: Possible Role of Synergism between DSS and HDCA in Increasing Fecal Bile Acid LevelsShiro Watanabe, Zhuoer Chen, Kyosuke Fujita, et al.
Biological & Pharmaceutical Bulletin|July 16, 2025
FLG249 Exhibits FXR Antagonist Activity by Inducing Dissociation of Both Corepressors and Coactivators from FXRYusuke Iguchi, Yukiko Yamashita, Keigo Gohda, et al.
Physical Review Letters|August 2, 2024
Anomalous Superfluid Density in a Disordered Charge-Density-Wave Material: Pd-Intercalated ErTe_{3}Yusuke Iguchi, Joshua A Straquadine, Chaitanya Murthy, et al.
Biological & Pharmaceutical Bulletin|August 13, 2024
FXR Antagonist FLG249 Lowers Hepatic Triacylglycerol and Serum Cholesterol Level in High-Fat Diet-Induced Obese MiceYusuke Iguchi, Yukiko Yamashita, Keigo Gohda, et al.
Bioorganic & Medicinal Chemistry|April 29, 2019
Identification of potent farnesoid X receptor (FXR) antagonist showing favorable PK profile and distribution toward target tissues: Comprehensive understanding of structure-activity relationship of FXR antagonistsNaoki Teno, Yukiko Yamashita, Arisa Masuda, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
The Review of Scientific Instruments|September 4, 2009
Development of special rotor for centrifugal separation of isotopes in solid pure metalsMasao Ono, Masanori Sueyoshi, Satoru Okayasu, et al.
Physical Review Letters|May 27, 2023
Microscopic Imaging Homogeneous and Single Phase Superfluid Density in UTe_{2}Yusuke Iguchi, Huiyuan Man, S M Thomas, et al.
Bioorganic & Medicinal Chemistry|April 7, 2023
Discovery of FXR/PPARγ dual partial agonistYukiko Yamashita, Keigo Gohda, Yusuke Iguchi, et al.
Bioorganic & Medicinal Chemistry|July 4, 2020
N<sup>1</sup>-Substituted benzimidazole scaffold for farnesoid X receptor (FXR) agonists accompanying prominent selectivity against vitamin D receptor (VDR)Arisa Masuda, Keigo Gohda, Yusuke Iguchi, et al.
ACS Medicinal Chemistry Letters|February 20, 2018
Nonacidic Chemotype Possessing <i>N</i>-Acylated Piperidine Moiety as Potent Farnesoid X Receptor (FXR) AntagonistsNaoki Teno, Yukiko Yamashita, Yusuke Iguchi, et al.
Biological & Pharmaceutical Bulletin|October 2, 2022
Hyodeoxycholic Acid (HDCA) Prevents Development of Dextran Sulfate Sodium (DSS)-Induced Colitis in Mice: Possible Role of Synergism between DSS and HDCA in Increasing Fecal Bile Acid LevelsShiro Watanabe, Zhuoer Chen, Kyosuke Fujita, et al.
Biological & Pharmaceutical Bulletin|July 16, 2025
FLG249 Exhibits FXR Antagonist Activity by Inducing Dissociation of Both Corepressors and Coactivators from FXRYusuke Iguchi, Yukiko Yamashita, Keigo Gohda, et al.
Physical Review Letters|August 2, 2024
Anomalous Superfluid Density in a Disordered Charge-Density-Wave Material: Pd-Intercalated ErTe_{3}Yusuke Iguchi, Joshua A Straquadine, Chaitanya Murthy, et al.
Biological & Pharmaceutical Bulletin|August 13, 2024
FXR Antagonist FLG249 Lowers Hepatic Triacylglycerol and Serum Cholesterol Level in High-Fat Diet-Induced Obese MiceYusuke Iguchi, Yukiko Yamashita, Keigo Gohda, et al.
Bioorganic & Medicinal Chemistry|April 29, 2019
Identification of potent farnesoid X receptor (FXR) antagonist showing favorable PK profile and distribution toward target tissues: Comprehensive understanding of structure-activity relationship of FXR antagonistsNaoki Teno, Yukiko Yamashita, Arisa Masuda, et al.
Pageof 4